When I Try to Imagine the Best Investment Opportunity for the Next 10 Years, Costco Stock Just Doesn't Make the Cut. That's Why I Keep Coming Back to This Stock.

The article argues Costco (COST) is a “great company” but an expensive stock, citing a ~0.6% dividend yield and valuation multiples of 47x P/E and 1.4x P/S vs multi-year averages. It turns more positive on McCormick (MKC), highlighting a historically high ~3.6% yield and lower valuation vs its own 5-year averages (9x P/E, 2x P/S, 2x P/B). The key near-term catalyst is McCormick’s planned acquisition of Unilever’s food business, which the article frames as value-accretive but requiring added leverage as earnings are pressured by inflation and softer sales.

Analysis

The market implication is not “quality vs. quality,” but “duration vs. valuation.” COST’s premium multiple leaves it highly sensitive to any slowdown in comp traffic, membership growth, or a benign deceleration in execution quality; in a 4-6% rate world, that type of long-duration staple story is vulnerable to multiple compression even if fundamentals stay strong. MKC is the opposite: low expectations, high yield, and a management team that can use the pending deal to re-rate the equity if integration and leverage come in cleaner than feared.

The first-order winner from a spread perspective is not necessarily MKC outright, but a relative-value setup versus expensive defensive retail. If the market rotates toward cash-flow yield and away from “compounder at any price,” MKC’s multiple has more room to expand than COST’s has room to go higher. The main second-order risk is that MKC’s acquisition introduces balance-sheet and integration drag exactly when consumer staples are already fighting input-cost pressure, so the equity could be dead money for several quarters even if the long-term thesis is intact.

Catalyst path is two-step: over days/weeks, the stock reaction will be dominated by financing terms, leverage, and any sign the deal forces dividend restraint or buyback pause; over 1-3 months, the key is whether management can frame credible synergies without implying margin dilution. Over 6-18 months, the real falsifier is continued stagnation in organic growth or a post-close deleveraging path that crowds out capital returns. For COST, what could reverse the bearish valuation view is a sustained reacceleration in membership monetization or a near-term deflationary environment that restores operating leverage.

Key Decisions for Investors

• Initiate a relative-value pair: long MKC / short COST, sized for 3-6 month valuation convergence; thesis works if COST multiple compresses 10-15% and MKC merely stabilizes on integration clarity.
• Delay fresh outright MKC longs until post-deal financing terms are disclosed; if leverage comes in above expectations, use any post-announcement selloff as a better entry point rather than chasing pre-close.
• For conservative exposure, prefer MKC over XLP as a single-name staples allocation over 6-18 months; the setup offers higher starting yield and more upside if the market rewards income and value.
• If holding COST, hedge with a short-dated call overwrite or partial profit-taking into any strength above the current valuation band; the stock has limited upside unless membership metrics surprise materially.